Events
2 minute read

Navigating Tricky Confidentiality and Conflicts Issues in the New Biosimilars Exchange Process

Kevin E. Noonan, Ph.D.June 7, 20134:30 pm - 5:30 pm

4:30-5:30 PM ET | June 7, 2013 | New York


MBHB Partner Kevin Noonan, Ph.D. is a featured presenter at this one-hour ACI-sponsored program.


Program Overview:




  • Complying with confidentiality mandates during the dossier exchange process



    • How do you use the information that you get access to during the patent dance?


    • Maintaining required confidentiality while remaining a zealous advocate for your company or client


  • Avoiding conflicts of interest as the lines between branded companies and generic companies blur in the biosimilars space



    • Will the arguments you made in one case come back to haunt you in another?


    • Applying traditional conflicts analysis and principals when agreeing to work for a client

This program is being conducted as part of the American Conference Institute’s (“ACI”) 4th Annual Conference on “Biosimilars: The Definitive Forum on the Legal, Regulatory and Commercial Realities of Biosimilars.”


Sponsored by: American Conference Institute


View complete details including registration at http://www.americanconference.com/2013/823/biosimilars/overview